TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | -1 | 5 | -2 | 3 | -2 | -13 | -2 |
P | %wins | 0 | 100 | 0 | 100 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/23 16:05 | 3/14/23 | MNK | Mallinckrodt Plc | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | MO | D | P | 42 | 8.47 | 0 | 5 | 7 | 75 | D | ||||||||||||||||
8/18/21 06:03 | 8/16/21 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | FL | D | P | 40 | 0.7900 | 0 | 50 | 34 | 197 | D | |||||||||||||||
6/8/20 16:10 | 6/4/20 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | FL | D | P | 57 | 1.14 | 0 | 50 | New | 50 | D | |||||||||||||||
3/12/19 16:45 | 3/12/19 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | NJ | DO | Exec CB | P | 203 | 11.97 | 0 | 17 | New | 17 | D | |||||||||||||||
8/24/15 18:28 | 8/24/15 | AGN | Allergan Plc | L2 | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | L2 | DO | Exec CB | P | 297 | 297.42 | 33 | 1 | 0 | 422 | D | 124 | 32 | 2 | -1 | -6 | -11 | -5 | -7 | -1 | 5 | -2 | 3 | -2 | -13 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |